pgaudet
pgaudet
I also wonder if the redundant information is never useful; for example to compare different coverage by PAINT vs InterProt, or to compare whether IEAs are confirmed experimentally, etc ......
We are also working on documentation for how we use relations in GO annotations - I would be happy to align our documentation with RO's.
what problem does that solve? by 'characteristic' do you mean, regulation of quality?
Is GO the only group using this relation? We plan to stop using the relation.
We can remove the relation from RO now, I think having it in GOREL until annotations are fixed is sufficient. Is this right @vanaukenk ?
Hello, We use for example GO:0033198 response to ATP 'response to stimulus' and ('has input' some 'ATP(4-)') Thanks, Pascale
Hi Karen, Thanks for looking into this. Your proposal "disruptive_polypeptide_truncation". We also need "disruptive_polypeptide_insertion". I wonder if it's possible to add 'indel' as a related synonym to all these, so...
Hi again Karen, Looking at this once more, in the proposal above, 'disruptive_polypeptide_truncation' should be replaced by 'disruptive_polypeptide_deletion'. To summarize: - disruptive_polypeptide_deletion - disruptive_polypeptide_insertion (disruptive_polypeptide_truncation may still be relevant, we...
@sylvainpoux are the different forms of cyclic-GMP-AMP mediating signaling in different pathways?
For my own information from https://www.nature.com/articles/s41467-018-06922-7